Tabela 2. Routine semen assessment before and after antioxidative supplementation.

All patients

Normozoospermic patients

Oligozoospermic patients

Asthenozoospermic patients

OAT patients

Before treat ment

After anti-oxida tive intake

p- value

Before treat ment

After anti-oxida tive intake

p- value

Before treat ment

After anti-oxida tive intake

p- value

Before treat ment

After anti-oxida tive intake

p- value

Before treat ment

After anti-oxida tive intake

p- value

MSOME criteria

Grade I

5.1 ± 5.4

6.6 ± 6.7

*

7.2 ± 6.1

8.3 ± 6.3

n.s.

3.4 ± 3.2

10.8 ± 7.5

*

5.1 ± 5.2

8.4 ± 7.0

*

2.6 ± 4.0

5.0 ± 7.2

n.s.

Grade II

39.7± 15.5

42.9 ± 14.6

n.s.

44.4± 13.0

47.1 ± 12.5

n.s.

47.1 ± 12.2

43.9 ± 9.0

n.s.

42.5± 11.7

41.8 ± 11.6

n.s.

26.9± 15.7

37.4 ± 15.8

**

Grade III

55.2± 18.1

50.5 ± 18.2

*

48.4 ± 15.6

44.6 ± 14.5

n.s.

49.5.0 ± 14.4

45.3 ± 10.2

*

52.4 ± 13.1

49.8 ± 14.8

*

70.5± 17.7

57.6 ± 20.1

**

Oligoasthenoteratozoospermia was defined according to WHO criteria. OAT= oligoasthenoteratozoospermia; n.s. = not significant; * = p< 0.05; **= p< 0.01; *** = p< 0.001